Guardant Health to Participate in Upcoming Investor Conferences

Go back to Guardant Health to Participate in Upcoming Investor Conferences

Bernstein SocGen Group Reiterates Outperform Rating on Guardant Health (GH)

February 10, 2025 7:37 AM EST

Bernstein SocGen Group analyst Eve Burstein reiterated an Outperform rating and $45.00 price target on Guardant Health (NASDAQ: GH)

The analyst comments "Guardant Health reported this morning that it has reached an agreement for a convertible note exchange. As a reminder, Guardant had $1.15B of convertible notes outstanding with maturity in 2027. The transaction is structured as follows: - $659.3M of outstanding convertible notes (at 0% interest rate with... More